Sachs is a renowned expert on health policy and drug law. She is a scholar of innovation policy whose work explores the interaction of intellectual property law, food and drug regulation and health law. Her work explores problems of innovation and access to new health care technologies. Sachs’ scholarship has or will have appeared in journals that include the Michigan Law Review, the Minnesota Law Review, the Harvard Law Review, the New England Journal of Medicine, and the Journal of the American Medical Association.
A final judgment invalidating the entire Affordable Care Act as unconstitutional would not only harm those in the individual market or Medicaid expansion—but would also jeopardize the ability of even more Americans to afford their prescription drugs.
The Trump Administration released a proposed rule Jan. 31 that could alter the way many drugs are priced and paid for among Medicare and Medicaid plans. The proposed regulation would eliminate the regulatory safe harbor for rebates as they exist today, said Rachel Sachs, an expert on drug policy and pricing at Washington University in St. Louis.
President Donald Trump has touted his new United States-Mexico-Canada Agreement as a way to boost the American economy. It may not, however, have any impact on one of his other campaign promises: reducing prescription costs for U.S. consumers, says a drug pricing expert at Washington University in St. Louis.
President Donald Trump, in a long-awaited speech May 11, took aim at reducing drug prices in America. But there was little in the speech or the administration’s plan that takes direct aim at industry, says an expert on drug policy at Washington University in St. Louis.
During his first year in office, President Donald Trump spoke about high drug prices but took little action to address the problem. His budget proposal, released this week, does lay out a strategy — though what is most notable is not what’s included, but rather what is missing. Rachel Sachs, an expert on drug pricing and policy at Washington University in St. Louis, weighs in.